Skip to main content
. 2022 Nov 14;11(11):1621. doi: 10.3390/antibiotics11111621

Table 1.

Three-year trend of resistance to βL-βLICs in KPC-Kp strains isolated from BSIs.

Antimicrobial Agent
% Resistance a
Total of KPC-Kp Isolates
(n = 116)
2018
(n = 62)
2019
(n =31)
2020
(n = 23)
Ceftazidime-avibactam 8.6%
10/116
6.5%
(4/62)
12.9%
(4/31)
8.7%
(2/23)
Meropenem-vaborbactam 9.5%
11/116
14.5%
(9/62)
3.2%
(1/31)
4.3%
(1/23)
Imipenem-relebactam 2.6%
3/116
1.6%
(1/62)
3.2%
(1/31)
4.3%
(1/23)

a Applying EUCAST breakpoints.